Levocetirizine Eg

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizine Eg, is a second‑generation H1 receptor antagonist presented as an oral tablet for oral use. It treats allergic rhinitis and chronic idiopathic urticaria in adults and children when prescribed.

GNH USA supplies Levocetirizine Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine is a second‑generation antihistamine that alleviates allergic conditions by blocking peripheral H1 receptors.

Allergic rhinitis: reduces sneezing, nasal congestion, itching and rhinorrhea. Chronic idiopathic urticaria: decreases wheal formation and itching, improving quality of life.

Levocetirizine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Drowsiness or mild sedation. - Headache. - Dry mouth. - Fatigue. - Altered taste perception. - Nausea.

Serious or Rare Side Effects: - Angioedema or severe swelling. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylactic reactions. - Cardiac arrhythmia (rare). - Hepatic enzyme elevation. - Severe psychiatric symptoms (rare).

Before initiating therapy, consider the following safety measures. - Pregnancy: consult a healthcare provider; use only if benefit outweighs risk. - Renal impairment: dose may require adjustment; monitor renal function. - Elderly patients: increased sensitivity to sedation; start with lowest effective dose. - Driving or operating machinery: avoid if drowsiness occurs. - Drug interactions: review all concomitant medications for potential additive effects. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levocetirizine may interact with several drug classes; monitoring is advised.

Major Interactions (Avoid): - Alcohol: may enhance sedation. - Central nervous system depressants (e.g., benzodiazepines): additive drowsiness. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase levocetirizine plasma levels.

Moderate Interactions (Monitor Closely): - Theophylline: possible reduction in antihistamine efficacy. - Ritonavir: may raise levocetirizine concentrations. - Other antihistamines: risk of cumulative anticholinergic effects.